2008 2019 Access Collective 
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive.
Cannabis Law Report
MARCH 3, 2020
Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. Effective Date: 2019. Providing patients safe access to therapeutic marijuana/cannabis. Status: Position Statement. IS NA STRONGLY SUPPORTS : . ?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 20, 2021
The creation of this standalone cannabis department is part of a larger effort to improve access to licensure, simplify regulatory oversight and support California businesses. Collectively, these dedicated public servants bring extensive experience from the state and local level to the leadership team. General Counsel – Matthew Lee.
Cannabis Law Report
MAY 26, 2022
The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016. Marijuana use at any level can impair driving performance. 1988, Jones et al., 1992, O’Malley and Wagenaar, 1991, Shults et al.,
Cannabis Law Report
JULY 24, 2022
It was not until the 1990s that psychedelics research was resumed, first with psilocybin and DMT, and since 2008 also with LSD. The collective term psychedelics or hallucinogens respectively (from Latin [h]al[l]ucinatio – thoughtless speech ) covers various substances that cause a perceptual and sensory disorder [2].
Cannabis Law Report
NOVEMBER 7, 2019
CannTrust was a wake up for the regulated Canadian market will Folium be the same for the USA as 2019 draws to a close. Colorado based Folium Biosciences, run by Kashif Shan, teamed up with Scott Dowty of publicly traded Australis ($AUSAF), to announce the launch of Folium Finance , April 2019. Super Zoo, Las Vegas 2019.
Cannabis Law Report
AUGUST 6, 2019
The nation collectively hopes that marijuana is indeed concurrently or subsequently re/de-scheduled out of the research-prohibitive Schedule 1 category into the Schedule 2 or Schedule 3 category. Already, the year shows a direction of solid marijuana reform with Tom Angell’s recent July 31, 2019 announcement that The 116th U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content